OH-PROAMPAC
Flexible packaging leader ProAmpac joined nkd® LIFE in celebrating their recognition as a finalist in the Best Environmentally-Friendly Packaging category of the 2019 World Beverage Innovation Awards . This award honored the “revolutionary” nkd TREK reusable water-purifying pouch that was developed in partnership with ProAmpac.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200205005184/en/
“Being named as a finalist in the 2019 World Beverage Innovation Awards draws attention to a revolutionary approach – a reusable, flexible packaging container for filtering water from taps, rivers, lakes and streams, which will be introduced to consumers in 2020,” stated Adam Grose, chief commercial officer for ProAmpac.
“The TREK pouch transforms water into safe, great tasting drinking water from sources without electricity,” according to Nik Soni from nkd LIFE. “It’s super-charging technology makes the water more alkaline and richer in antioxidants,” continues Soni.
The nkd LIFE proprietary filter screws into the removable cap in a BPA-free, leak-proof, dishwasher-safe pouch. By using the reusable pouch in combination with a nkd Life water reusable filter, this innovative approach effectively replaces 300 single use plastic bottles per filter going into landfills or being dumped into the sea. Over the course of a year this can amount to 50kg of saved plastic waste per person.
“We wanted to address the proliferation of discarded single use water bottles by creating a sustainable, portable and compact solution. This resulted in a flexible pouch, easy to carry and store, coupled with exceptional filtration abilities in a lightweight, space-saving design inherent to flexible packaging,” stated Soni.
Manuel Jaggi, product development manager for ProAmpac states, “Replacing the rigid bottle with a flexible pouch has big impact on the sustainability of the product, as flexible packaging increases the product-to-package ratio, reduces energy use during manufacturing, and reduces the resources required for delivery, distribution and storage.”
Jaggi continues, “To develop nkd’s TREK pouch, we utilized a high-performance laminated structure that has superior mechanical properties to reduce the amount of materials previously used in the rigid container.”
To learn more about how ProAmpac uses Collaborative Innovation to bring more sustainable products and solutions to market, contact marketing at Marketing@ProAmpac.com .
About nkd Life
nkd LIFE is a British Company specializing in the design, development, manufacture and sales of cutting-edge water purification and filtration technologies that stand clearly ahead of the market in terms of design, technology, quality, functionality and ease of use. nkdLIFE.com
About ProAmpac
ProAmpac is a leading global flexible packaging company with a comprehensive product offering. We provide creative packaging solutions, industry-leading customer service and award-winning innovation to a diverse global marketplace. ProAmpac’s approach to sustainability – ProActive Sustainability® – provides innovative sustainable flexible packaging products to help our customers achieve their sustainability goals. We are guided in our work by four core values that are the basis for our success: Integrity, Intensity, Innovation, and Involvement. Cincinnati-based ProAmpac is owned by Pritzker Private Capital along with management and co-investors. For more information, visit ProAmpac.com .
About Pritzker Private Capital
Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm's differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. For more information, visit PPCPartners.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200205005184/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NEC to Acquire CSG, Strengthening Its Position as a Global Leader in Digital Transformation29.10.2025 08:44:00 CET | Press release
NEC Corporation (TSE: 6701) (“NEC”) and CSG Systems International, Inc. (NASDAQ: CSGS) (“CSG”) today announced they have entered into a definitive agreement under which NEC will acquire CSG for US$80.70 per share in cash, for a total enterprise value of approximately US$2.9 billion, or JPY438.5 billion, including debt. The transaction price represents a 17.38% premium over CSG’s closing price of US$68.75 on October 28, 2025, and a 23.07% premium to the volume-weighted average price (VWAP) of CSG common stock for the 30 days ending October 28, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029203825/en/ The transaction strengthens NEC's position as a leader in next-generation digital solutions and accelerates AI and cloud-driven innovation for customers across industries. It will bring together complementary software and services across digital transformation, expanding NEC's software-as-a-service (SaaS) portfolio, c
Samsung Bioepis to Commercialize BYOOVIZ® (ranibizumab) in Europe from January 202629.10.2025 08:00:00 CET | Press release
Samsung Bioepis will assume full commercial responsibility for BYOOVIZ® (ranibizumab) upon full transition of Biogen’s commercialization rights back to Samsung Bioepis effective as of January 2026BYOOVIZ, approved by the European Commission (EC) in August 2021 as the first ophthalmology biosimilar in Europe, has been commercially available in several European countries since March 2023 Samsung Bioepis Co., Ltd. announced today that the company has entered into an Asset Purchase Agreement (APA) with Biogen regarding Samsung Bioepis’ two ophthalmology assets: BYOOVIZ® (ranibizumab), a biosimilar referencing Lucentisi (ranibizumab) and OPUVIZ™ (aflibercept), a biosimilar referencing Eyleaii (aflibercept) — in Europe. Samsung Bioepis will have full responsibility for commercialization of BYOOVIZ upon the transfer of commercial rights from Biogen back to Samsung Bioepis, effective as of January 2026. “We are pleased to announce our direct commercialization initiative for BYOOVIZ in Europe.
Recover™ Secures Multi-Year Recycled Cotton Agreement with H&M29.10.2025 08:00:00 CET | Press release
Recover™ has signed a multi-year agreement with H&M to support the integration of its recycled cotton fiber, RCotton, for use in H&M’s products. Since early 2024, H&M and Recover™ have collaborated on product development, which now enables scaled commercial introduction of Recover™ mechanically recycled cotton into H&M’s collections. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029456063/en/ Recover™ has signed a multi-year agreement with H&M to support the integration of its recycled cotton fiber, RCotton, for use in H&M’s products. Recover™ combines more than 75 years of textile recycling expertise with advanced processes that deliver traceability and consistent quality at an industrial scale, operating five recycling hubs located at the heart of textile production streams in Europe, Asia and the Americas. These capabilities are essential for a global fashion player like H&M Group, where transparency, fiber performanc
Ant Group’s AQ Tops China’s AI-Native Healthcare Apps, Launching New Features for Chronic Disease and Elderly Care29.10.2025 07:28:00 CET | Press release
Ant Group’s AI healthcare service AQ is now among China’s top 7 AI-native apps and the only healthcare app on the list, based on monthly active users, according to the latest report from QuestMobile on AI applications in China. Within this group, AQ achieved the highest compound growth rate of 83.4%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028871468/en/ Ant Group’s AI healthcare platform AQ introduces new features, including family health record sharing, to support chronic disease management and elderly care. Since its public beta as an Alipay mini-program in September 2024 and official launch as an independent app in China in June 2025, the AQ platform has served 140 million users as of September 2025. It provides more than 100 AI-powered services, including doctor recommendations, medical report analysis, and personalized health guidance. These developments come amid China’s ongoing demographic transformation. By
Aramco and Yokogawa Achieve a Major Milestone with Commissioning of Multiple Autonomous Control AI Agents at Major Gas Facility29.10.2025 03:00:00 CET | Press release
- Groundbreaking deployment successfully optimizes gas treatment unit, reducing energy and chemical use - Yokogawa Electric Corporation (TOKYO: 6841, “Yokogawa”), a leader in process automation technology, announces it has achieved a historic milestone in the deployment of industrial artificial intelligence (AI) solutions with Aramco, one of the world’s leading integrated energy and chemicals companies. Multiple autonomous control AI*1 agents have been successfully implemented by Yokogawa at Aramco’s Fadhili Gas Plant in the Kingdom of Saudi Arabia to enhance operational efficiency. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028792329/en/ Fadhili Gas Plant (Courtesy of Aramco) The AI solution developed by Yokogawa uses multiple, coordinated AI agents of the Factorial Kernel Dynamic Policy Programming (FKDPP)*2 reinforcement learning-based AI algorithm to directly and autonomously control and optimize acid gas removal
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
